| Date Filed | Type | Description |
| 10/10/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/06/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 10/04/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 440,752 shares
@ $10.8, valued at
$4.8M
Sold 606,221 shares
@ $10.25, valued at
$6.2M
Sold 153,027 shares
@ $10.11, valued at
$1.5M
Exercised 440,752 options to buy
@ $3.85, valued at
$1.7M
Exercised 606,221 options to buy
@ $3.85, valued at
$2.3M
Exercised 153,027 options to buy
@ $3.85, valued at
$589.2k
|
|
| 10/04/2023 |
SC 13D/A
| Roivant Sciences Ltd. reports a 55.3% stake in Immunovant, Inc. |
| 10/04/2023 |
4
| Roivant Sciences Ltd. (10% Owner) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 4,473,684 shares
@ $38, valued at
$170M
Bought 1,526,316 shares
@ $38, valued at
$58M
|
|
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
4
| Pulik Richard (CFO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 2,483 shares
@ $11.86, valued at
$29.4k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
| 10/02/2023 |
4
| SVF Investments (UK) Ltd (10% Owner) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 10,000,000 shares
@ $12.6, valued at
$126M
|
|
| 10/02/2023 |
4
| Gold Daniel Allen (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 8,957 shares
@ $11.55, valued at
$103.5k
Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 3,094,899 shares
@ $11.55, valued at
$35.7M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
| 10/02/2023 |
4
| QVT Financial LP (10% Owner) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 8,957 shares
@ $11.55, valued at
$103.5k
Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 3,094,899 shares
@ $11.55, valued at
$35.7M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 09/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/24/2023 |
4
| Kumar Rakhi (Chief Accounting Officer) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 1,378 shares
@ $10.83, valued at
$14.9k
|
|
| 08/24/2023 |
4
| Venker Eric (President & COO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 16,105 shares
@ $10.83, valued at
$174.4k
|
|
| 08/24/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 11,015 shares
@ $10.83, valued at
$119.3k
|
|
|